Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FRY antisense RNA 1 (FRY-AS1) is a long non-coding RNA transcribed from the reverse strand of the FRY gene locus on chromosome 13. As an antisense RNA, it may function to regulate the expression of the FRY gene or neighboring genes by forming RNA-RNA duplexes, altering mRNA stability, or affecting chromatin and epigenetic states. Antisense RNAs are a class of regulatory molecules broadly involved in post-transcriptional gene regulation, genome organization, and epigenetic modification, but the specific targets and functions of FRY-AS1 are yet to be clearly defined in the literature. FRY-AS1 is best classified as a regulatory lncRNA (natural antisense transcript), not as a receptor, enzyme, transporter, or other typical drug target class. There is no evidence to suggest FRY-AS1 is a known therapeutic target or that it interacts directly with drugs, nor is it established as a disease biomarker. Its role is inferred based on the general functions of antisense RNAs in cellular gene regulation.
Not applicable; there are no drugs known to target FRY-AS1 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FRY antisense RNA 1 (FRY-AS1).